COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 2621: Articles 26201-26210  | Next

Greater risk of severe COVID-19 in non-White ethnicities is not explained by cardiometabolic, socioeconomic, or behavioural factors, or by 25(OH)-vitamin D status: study of 1,326 cases from the UK Biobank
Raisi-Estabragh, Z., McCracken, C., Bethell, M. S., Cooper, J., Cooper, C., Caulfield, M. J., Munroe, P. B., Harvey, N. C., Petersen, S. E.
10.1101/2020.06.01.20118943 — Posted: 2020-06-02 Discussion: Onsite
Trauma-spectrum symptoms among the Italian general population in the time of the COVID-19 outbreak.
Rossi, R., Socci, V., Talevi, D., Niolu, C., Pacitti, F., Di Marco, A., Rossi, A., Siracusano, A., Di Lorenzo, G., Olff, M.
10.1101/2020.06.01.20118935 — Posted: 2020-06-02
The Mathematics of Testing with Application to Prevalence of COVID-19
Hanin, L.
10.1101/2020.05.31.20118703 — Posted: 2020-06-02
Evolutionary trends of the COVID-19 epidemic and effectiveness of government interventions in Nigeria: A data-driven analysis.
Odukoya, O. O., Adeleke, I. A., Jim, C. S., Isikekpei, B. C., Obiodunukwe, C. M., Lesi, F. e., Osibogun, A., Ogunsola, F.
10.1101/2020.05.29.20110098 — Posted: 2020-06-02 Discussion: Offsite
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency
Ferrari, D., Milic, J., Tonelli, R., Ghinelli, F., Meschiari, M., Volpi, S., Faltoni, M., Franceschi, G., Iadisernia, V., Yaacoub, D., Ciusa, G., Bacca, E., Rogati, C., Tutone, M., Burastero, G., Raimondi, A., Menozzi, M., Franceschini, E., Cuomo, G., Corradi, L., Orlando, G., Santoro, A., Di Gaetano, M., Puzzolante, C., Carli, F., Bedini, A., Fantini, R., Tabbi, L., Castaniere, I., Busani, S., Clini, E., Girardis, M., Sarti, M., Cossarizza, A., Mussini, C., Mandreoli, F., Missier, P., Guaraldi, G.
10.1101/2020.05.30.20107888 — Posted: 2020-06-02
Endotoxemia and circulating bacteriome in severe COVID-19 patients
Sirivongrangson, P., Kulvichit, W., Payungporn, S., Pisitkun, T., Chindamporn, A., Peerapornratana, S., Pisitkun, P., Chitcharoen, S., Sawaswong, V., Worasilchai, N., Kampunya, S., Putcharoen, O., Tawitsri, T., Leelayuwatanakul, N., Kongpolprom, N., Phoophiboon, V., Sriprasart, T., Samransamruajkit, R., Tungsanga, S., Tiankanon, K., Lumlertgul, N., Leelahavanichkul, A., Sriphojanart, T., Tantawichien, T., Thisyakorn, U., Chirathaworn, C., Praditpornsilpa, K., Tungsanga, K., Eiam-Ong, S., Sitprija, V., Kellum, J. A., Srisawat, N.
10.1101/2020.05.29.20109785 — Posted: 2020-06-02 Discussion: Offsite
POOLING FOR SARS-CoV-2 CONTROL IN CARE INSTITUTIONS
Cabrera, J. J., Rey, S., Perez, S., Martinez-Lamas, L., Cores-Calvo, O., Torres, J., Porteiro, J., Garcia-Comesana, J., Regueiro, B. J.
10.1101/2020.05.30.20108597 — Posted: 2020-06-02
Potential impact of Covid-19 response measures on invasive pneumococcal disease in England and Wales
Choi, Y. H., Miller, E.
10.1101/2020.06.01.20119057 — Posted: 2020-06-02
Quantitative assessment of the risk of airborne transmission of SARS-CoV-2 infection: prospective and retrospective applications
Buonanno, G., Morawska, L., Stabile, L.
10.1101/2020.06.01.20118984 — Posted: 2020-06-02 Discussion: Onsite
CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients
Dominguez Horta, M. d. C.
10.1101/2020.05.27.20110601 — Posted: 2020-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).